| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 核素药物(元) | 503,357,613.41 | 1,012,066,389.09 | 499,471,173.31 | 1,017,334,254.84 | 502,378,547.61 |
| 原料药相关产品(元) | 611,040,395.44 | 1,255,393,593.67 | 657,180,371.15 | 1,677,555,795.64 | 952,893,490.85 |
| 制剂产品(元) | 182,207,723.64 | 325,491,662.12 | 179,065,066.84 | 400,155,803.05 | 263,379,078.63 |
| 其他产品(元) | 87,106,150.37 | 275,984,892.84 | 84,994,763.87 | 180,602,033.10 | 66,359,345.24 |
| 营业成本(元) | |||||
| 核素药物(元) | 164,765,838.43 | 312,964,145.35 | 135,111,890.45 | 277,521,946.57 | 145,873,812.59 |
| 原料药相关产品(元) | 379,453,727.54 | 875,058,335.28 | 482,407,339.55 | 1,239,748,447.09 | 711,270,677.87 |
| 制剂产品(元) | 110,046,070.02 | 196,168,248.15 | 110,307,302.49 | 177,607,998.66 | 83,384,725.00 |
| 其他产品(元) | 85,218,882.20 | 132,337,959.51 | 58,642,734.46 | 111,079,607.06 | 48,422,514.96 |
| 毛利(元) | |||||
| 核素药物(元) | 338,591,774.98 | 699,102,243.74 | 364,359,282.86 | 739,812,308.27 | 356,504,735.02 |
| 原料药相关产品(元) | 231,586,667.90 | 380,335,258.39 | 174,773,031.60 | 437,807,348.55 | 241,622,812.98 |
| 制剂产品(元) | 72,161,653.62 | 129,323,413.97 | 68,757,764.35 | 222,547,804.39 | 179,994,353.63 |
| 其他产品(元) | 1,887,268.17 | 143,646,933.33 | 26,352,029.41 | 69,522,426.04 | 17,936,830.28 |
| 毛利率(%) | |||||
| 核素药物(%) | 67.27 | 69.08 | 72.95 | 72.72 | 70.96 |
| 原料药相关产品(%) | 37.90 | 30.30 | 26.59 | 26.10 | 25.36 |
| 制剂产品(%) | 39.60 | 39.73 | 38.40 | 55.62 | 68.34 |
| 其他产品(%) | 2.17 | 52.05 | 31.00 | 38.49 | 27.03 |
| 收入构成(%) | |||||
| 核素药物(%) | 36.38 | 35.28 | 35.16 | 31.06 | 28.14 |
| 原料药相关产品(%) | 44.16 | 43.76 | 46.26 | 51.21 | 53.38 |
| 制剂产品(%) | 13.17 | 11.35 | 12.60 | 12.22 | 14.76 |
| 其他产品(%) | 6.30 | 9.62 | 5.98 | 5.51 | 3.72 |
| 毛利构成(%) | |||||
| 核素药物(%) | 52.56 | 51.69 | 57.45 | 50.34 | 44.78 |
| 原料药相关产品(%) | 35.95 | 28.12 | 27.56 | 29.79 | 30.35 |
| 制剂产品(%) | 11.20 | 9.56 | 10.84 | 15.14 | 22.61 |
| 其他产品(%) | 0.29 | 10.62 | 4.15 | 4.73 | 2.25 |